Jake R. Gawlak, Associate, U.S. Financial Restructuring

Jake R. Gawlak

Associate

Areas of Focus

Jake R. Gawlak, Associate, U.S. Financial Restructuring

Jake R. Gawlak

Associate

jake.gawlak@akingump.com

Areas of Focus

Save as PDF

Share This Biography

Biography
  • Represents institutional investors and investment funds in connection with domestic and cross-border private placement transactions, first and second lien lending arrangements, mezzanine and other subordinated debt financings and other secured and unsecured finance transactions.
  • Certified Public Accountant (CPA).

Jake is an associate in the firm’s corporate group. Jake assists on advising clients in a variety of corporate finance transactions, including debt and equity private placement financings, secured and unsecured lending transactions and amendments and restructuring of all of the foregoing.

Representative Work
  • Represented investment funds managed by Pharmakon Advisors in a $500 million senior secured term loan to Mineralys Therapeutics.
  • Represented investment funds managed by Pharmakon in a $250 million senior secured term loan to Zenas BioPharma.
  • Advised Paine Schwartz Partners and HGS BioScience in acquisition of NutriAg Ltd.
  • Represented investment funds managed by Pharmakon in its up to $500 million debt facility financing for Valneva SE.
  • Represented investment funds managed by Pharmakon in its up to $125 million credit facility for Precigen.
  • Represented investment funds managed by Pharmakon in its debt financing for Optinose’s sale to Paratek Pharmaceuticals.
  • Represented investment funds managed by Pharmakon Advisors in its $250 million debt financing for Geron Corporation.
  • Represented investment funds managed by Pharmakon Advisors in its term loan to Alphatec Holdings.
  • Represented investment funds managed by Pharmakon in its $646 million secured financing to fund Collegium’s acquisition of Ironshore Therapeutics.
  • Advised Kennedy Lewis in a $50 million growth investment in Douglas Elliman.
  • Represented investment funds managed by Pharmakon Advisors in a $200 million commitment to Tarsus Pharmaceuticals.
  • Advised institutional investors in a private placement of $90 million of senior secured notes issued by a Chilean agricultural producer and distributor. The notes were guaranteed by subsidiaries organized in, and secured with collateral located in, Chile, Mexico, Peru and the United States.
  • Advised institutional investors in connection with a private placement of $55 million senior secured notes issued by a global financial technology firm.

Education
  • J.D., University of Connecticut School of Law, 2022

  • M.Acc., University of Connecticut, 2014

  • B.S., University of Connecticut, 2014

Bar Admissions
  • Connecticut

  • New York

Affiliations and Public Service

• Member, Connecticut Bar Association

Insights and Achievements

          Related Content

          People

          Distinguished by our areas of focus, as a cohesive and integrated firm, we are defined by the caliber of our work, the responsiveness of our service and a culture that is rooted in collaboration and forward-thinking.

          We Also Recommend

          Loading...
          Loading...
          Loading...
          Loading...